BR112013008528A2 - métodos para tratar psoríase - Google Patents

métodos para tratar psoríase

Info

Publication number: BR112013008528A2
Authority: BR; Brazil
Prior art keywords: methods; treat psoriasis; psoriasis; treat
Prior art date: 2010-10-06

Application number

BR112013008528A

Other languages

English (en)

Inventor

Allen Williams David

K Chartash Elliot

Mario Valdes Joaquim

Gordon Kenneth

Kaul Martin

Olds Heckaman Michele

Sundaram Murali

M Mulani Parvez

G B Langley Richard

K Paulson Susan

C Harris Tom

Bao Yanjun

Gu Yihua

Original Assignee

Abbvie Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-10-06

Filing date

2011-10-06

Publication date

2019-09-24

2011-10-06 Application filed by Abbvie Inc filed Critical Abbvie Inc

2019-09-24 Publication of BR112013008528A2 publication Critical patent/BR112013008528A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

BR112013008528A 2010-10-06 2011-10-06 métodos para tratar psoríase BR112013008528A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US39059010P	2010-10-06	2010-10-06
US201161453541P	2011-03-16	2011-03-16
PCT/US2011/055140 WO2012048134A2 (en)	2010-10-06	2011-10-06	Methods for treating psoriasis

Publications (1)

Publication Number	Publication Date
BR112013008528A2 true BR112013008528A2 (pt)	2019-09-24

Family

ID=45928439

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112013008528A BR112013008528A2 (pt)	2010-10-06	2011-10-06	métodos para tratar psoríase

Country Status (14)

Country	Link
US (1)	US20120189637A1 (pt)
EP (1)	EP2624867A4 (pt)
JP (1)	JP2013542209A (pt)
KR (1)	KR20130130713A (pt)
CN (1)	CN103813804A (pt)
AU (1)	AU2011311965A1 (pt)
BR (1)	BR112013008528A2 (pt)
CA (1)	CA2813208A1 (pt)
IL (1)	IL225623A0 (pt)
MX (1)	MX2013003920A (pt)
RU (1)	RU2013120322A (pt)
SG (1)	SG189836A1 (pt)
TW (1)	TW201233395A (pt)
WO (1)	WO2012048134A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010515774A (ja) *	2007-01-16	2010-05-13	アボット・ラボラトリーズ	乾せんの治療方法
BRPI0908715A2 (pt)	2008-03-18	2016-05-03	Abbott Lab	métodos para tratamento da psoríase
EP2350649A4 (en) *	2008-11-28	2012-11-14	Abbott Lab	STABLE ANTIBODY COMPOSITIONS AND METHODS FOR STABILIZING THE SAME
CA2773556A1 (en) *	2009-09-14	2011-03-17	Abbott Laboratories	Methods for treating psoriasis
JO3244B1 (ar)	2009-10-26	2018-03-08	Amgen Inc	بروتينات ربط مستضادات il – 23 البشرية
AU2014238148A1 (en) *	2013-03-15	2015-10-08	Amgen Inc.	Methods for treating psoriasis using an anti-IL-23 antibody
TWI775827B (zh) *	2017-03-31	2022-09-01	日商明治製菓藥業股份有限公司	水性製劑及裝入注射器之水性製劑以及抗體蛋白去凝集劑及抗體蛋白去凝集方法
EP3801590A4 (en) *	2018-05-29	2022-03-16	Abcentra, LLC	COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
EP3824295A4 (en) *	2018-07-18	2022-04-27	Janssen Biotech, Inc.	PREDICTORS OF PROLONGED RESPONSE AFTER TREATMENT WITH AN ANTI-IL23 SPECIFIC ANTIBODY
TWI725532B (zh) *	2018-09-11	2021-04-21	美商美國禮來大藥廠	治療牛皮癬之方法
JP2022544050A (ja) *	2019-07-30	2022-10-17	アケソ・バイオファーマ・インコーポレイテッド	抗ヒトｐ４０タンパク質ドメイン抗体及びその使用
CN111265529B (zh) *	2020-02-22	2021-07-23	南京大学	蛋白酪氨酸磷酸酶shp2抑制剂在制备治疗银屑病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090280065A1 (en) *	2006-04-10	2009-11-12	Willian Mary K	Uses and Compositions for Treatment of Psoriasis
BRPI0908715A2 (pt) *	2008-03-18	2016-05-03	Abbott Lab	métodos para tratamento da psoríase
CA2773556A1 (en) *	2009-09-14	2011-03-17	Abbott Laboratories	Methods for treating psoriasis

2011
- 2011-10-06 RU RU2013120322/15A patent/RU2013120322A/ru not_active Application Discontinuation
- 2011-10-06 JP JP2013532949A patent/JP2013542209A/ja active Pending
- 2011-10-06 CA CA2813208A patent/CA2813208A1/en not_active Abandoned
- 2011-10-06 KR KR1020137011665A patent/KR20130130713A/ko not_active Application Discontinuation
- 2011-10-06 TW TW100136381A patent/TW201233395A/zh unknown
- 2011-10-06 EP EP11831616.5A patent/EP2624867A4/en not_active Withdrawn
- 2011-10-06 BR BR112013008528A patent/BR112013008528A2/pt not_active IP Right Cessation
- 2011-10-06 MX MX2013003920A patent/MX2013003920A/es not_active Application Discontinuation
- 2011-10-06 AU AU2011311965A patent/AU2011311965A1/en not_active Abandoned
- 2011-10-06 US US13/267,658 patent/US20120189637A1/en not_active Abandoned
- 2011-10-06 WO PCT/US2011/055140 patent/WO2012048134A2/en active Application Filing
- 2011-10-06 SG SG2013025325A patent/SG189836A1/en unknown
- 2011-10-06 CN CN201180058745.8A patent/CN103813804A/zh active Pending
2013
- 2013-04-07 IL IL225623A patent/IL225623A0/en unknown

Also Published As

Publication number	Publication date
KR20130130713A (ko)	2013-12-02
RU2013120322A (ru)	2014-11-20
TW201233395A (en)	2012-08-16
CN103813804A (zh)	2014-05-21
SG189836A1 (en)	2013-06-28
EP2624867A2 (en)	2013-08-14
EP2624867A4 (en)	2014-04-23
US20120189637A1 (en)	2012-07-26
AU2011311965A1 (en)	2013-03-28
CA2813208A1 (en)	2012-04-12
JP2013542209A (ja)	2013-11-21
WO2012048134A3 (en)	2012-06-14
MX2013003920A (es)	2013-06-03
IL225623A0 (en)	2013-06-27
WO2012048134A2 (en)	2012-04-12

Publication	Publication Date	Title
BR112013033720A2 (pt)	2016-08-16	método para tratar eczema
BR112013008528A2 (pt)	2019-09-24	métodos para tratar psoríase
BR112014006324A2 (pt)	2016-06-07	método para tratar hcv
CO7061082A2 (es)	2014-09-19	Compuestos para tratar la artrofia muscular espinal
BR112014006702A2 (pt)	2017-06-13	método para tratar osteoporose
CL2015001157A1 (es)	2015-10-16	Composiciones y métodos para tratar proteinopatías.
DK2707030T3 (da)	2020-05-18	Cancerbehandlinger
BRPI1011226A2 (pt)	2016-03-15	métodos para tratar condições relacionadas ao cabelo
BR112015002681A2 (pt)	2018-08-28	método para tratar um paciente e kit
BRPI1008253A2 (pt)	2015-08-25	Metoso para tratar biomassa
BRDI7106340S (pt)	2014-05-13	Configuração aplicada em mamadeira
BR112014009785A2 (pt)	2017-04-25	método para tratar ou reduzir efp
BRDI7106333S (pt)	2014-05-13	Configuração aplicada em mamadeira
BR112013007298A2 (pt)	2016-06-14	método para produzir composição de borracha
BRDI7106341S (pt)	2014-05-13	Configuração aplicada em mamadeira
BR112013022254A2 (pt)	2018-06-12	método e disposição para gerar oxigênio
BRDI7106337S (pt)	2014-05-13	Configuração aplicada em mamadeira
BR112013023465A2 (pt)	2016-12-13	método para produzir l-cisteína
EP2709665A4 (en)	2014-11-12	TREATMENT OF PSORIASIS
BR112013013580A2 (pt)	2016-09-06	processo para produzir hidrocarbonetos aomáticos
BR112015015258A2 (pt)	2017-09-26	métodos para tratar distúrbios do trato gastrintestinal
BR112012022525A2 (pt)	2019-09-24	método para produzir butanol
BRDI7105384S (pt)	2014-05-06	Configuração aplicada em banda de rodagem para pneumático
BRDI7105383S (pt)	2014-05-06	Configuração aplicada em banda de rodagem para pneumático
BR112013033851A2 (pt)	2017-02-07	método para formar sevoflurano

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.